The company operates in two main business segments: prescription medicines and generics, through its Sandoz division.
Novartis is a leader in pharmaceutical research and development, with a diverse portfolio that spans across key therapeutic areas such as oncology, cardiology, immunology, ophthalmology, and neuroscience. The company is known for its innovative treatments in cancer care, including targeted therapies and immuno-oncology drugs. Additionally, Novartis is a significant player in the field of gene therapies, especially in areas like blood disorders and inherited conditions.
Through its Sandoz division, Novartis also produces generic drugs and biosimilars, which are more affordable alternatives to branded medicines. This helps expand access to essential treatments for patients around the world.
Novartis places a strong emphasis on cutting-edge technologies and data-driven approaches, incorporating artificial intelligence and digital solutions into its research and development processes. The company is committed to improving global health, with a focus on addressing unmet medical needs, enhancing quality of life, and providing sustainable solutions to healthcare challenges.
Operating in over 140 countries, Novartis is dedicated to driving innovation and making a positive impact on the lives of patients worldwide.
Our April Webinar is hosted by Tawuniya, Saudi Arabia’s largest and leading private insurer pioneering Value-Based Health Care (VBHC).
24 April 2025
09:00 EDT | 14:00 BST | 15:00 CEST | 17.00 Riyadh time
Presented By: Tawuniya
As healthcare systems shift from fee-for-service to value-based models, payers face the challenge of integrating VBHC principles to achieve better patient outcomes and cost-effective care. Discover how trusted partnerships with providers and mutual risk-sharing agreements can deliver higher quality care while driving value-based reimbursement.
What You Will Learn:
Don’t miss this opportunity to learn from industry leaders and gain practical insights into transforming healthcare financing with VBHC.
REGISTER NOW
![]() |
![]() |
|
---|---|---|
Dr Othman Al-Kassabi | Dr Mohammad Al-Saeed | |
CEO of Tawuniya | CEO of Health Sector Office |
![]() |
![]() |
|
---|---|---|
Dr Hadi Al-Enazy, | Dr Mohamed Kamal, | |
Senior Executive Director of Quality, | Medical Analytics Director | |
Governance and Transformation |
Seven Years of VBHC in Brazil: Lessons & Future Perspectives
27 March 2025
09:00 EST | 14:00 GMT | 15:00 CET | 11.00 BRASILIA
Presented By: Hospital Moinhos de Vento
Join our Knowledge Partner Hospital Moinhos de Vento (HMV), the pioneer in using the ICHOM framework to elevate patient outcomes in Brazil. Over the past seven years, HMV has implemented PROMs across nine diverse health conditions—from stroke and heart failure to cancers, orthopedic surgeries, neonatal care, and even COVID-19. Experts will share key insights on how these efforts have improved care quality, redesigned care pathways, and addressed challenges along the way.
In this webinar, you will learn:
Speakers
Mohammed Parrini,
Chief Executive Officer at Hospital Moinhos de Vento
Carisi Polanczyk,
Head of the Cardiology Service at Hospital Moinhos de Vento
Luiz Antonio Nasi
Chief Medical Officer at Hospital Moinhos de Vento
Arthur Pille
Attending Neurologist at Hospital Moinhos de Vento
Sheila Martins
Head of Neurology at Hospital Moinhos de Vento
Speakers
Zofia Das-Gupta (Moderator)
Senior Director, Outcomes Implementation & Accreditation
ICHOM
Sumalee Samakkanonthakan, RN, M.N.S. (Adult Nursing)
Manager of Center of Excellence Heart (CoE Heart)
Bangkok Hospital Pattaya
Transform your approach to cardiac surgery care by learning:
Highlights: